Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.
A new ACC/AHA dyslipidemia guideline and editorial argue that guideline development is rigorous but can lag behind ...
The 2026 NCCN updates represent a convergence of biological precision and patient-driven lifestyle changes. By integrating ...
It turns out that Tweeting about RCTs 100+ times is a lot easier than delivering even a single RCT.